US EditionA randomized trial of a blood thinner after severe COVID-19 to prevent clotting events
Summary by News Medical
1 Articles
1 Articles
All
Left
Center
1
Right
A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events
In a recent prospective study published in the Annals of Internal Medicine Journal, researchers in the United States (US) and Spain performed a randomized controlled trial (RCT) across 127 US hospitals between 2021 and 2022.
·United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
